We pretreated the cells with different doses of recombinant human IFN-α2, -β, -λ4, and -γ overnight and then challenged them with SARS-CoV-2 (multiplicity of infection [MOI] of 0.005 based on Vero E6 cells). This evidence concerns the gene IFNA2 and infection.